| Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more G Bonadonna, U Veronesi, C Brambilla, L Ferrari, A Luini, M Greco, ... JNCI: Journal of the National Cancer Institute 82 (19), 1539-1545, 1990 | 828 | 1990 |
| The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients R Silvestrini, S Veneroni, MG Daidone, E Benini, P Boracchi, M Mezzetti, ... JNCI: Journal of the National Cancer Institute 86 (7), 499-504, 1994 | 617 | 1994 |
| ‘Daunomycin’, a new antibiotic of the rhodomycin group A Di Marco, M Gaetani, P Orezzi, BM Scarpinato, R Silvestrini, M Soldati, ... Nature 201 (4920), 706-707, 1964 | 356 | 1964 |
| p53 as an independent prognostic marker in lymph node-negative breast cancer patients R Silvestrini, E Benini, MG Daidone, S Veneroni, P Boracchi, V Cappelletti, ... JNCI: Journal of the National Cancer Institute 85 (12), 965-970, 1993 | 326 | 1993 |
| Cell kinetics as a prognostic marker in node‐negative breast cancer R Silvestrini, MG Daidone, G Gasparini Cancer 56 (8), 1982-1987, 1985 | 239 | 1985 |
| Cell proliferation and its relationship to clinical features and relapse in breast cancers C Gentili, O Sanfilippo, R Silvestrini Cancer 48 (4), 974-979, 1981 | 196 | 1981 |
| Interaction of some daunomycin derivatives with deoxyribonucleic acid and their biological activity A Di Marco, F Zunino, R Silvestrini, C Gambarucci, RA Gambetta Biochemical Pharmacology 20 (6), 1323-1328, 1971 | 188 | 1971 |
| p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients. R Silvestrini, E Benini, S Veneroni, MG Daidone, G Tomasic, ... Journal of clinical oncology 14 (5), 1604-1610, 1996 | 176 | 1996 |
| Labeling index as a prognostic marker in non-Hodgkin's lymphomas A Costa, G Bonadonna, E Villa, P Valagussa, R Silvestrini Journal of the National Cancer Institute 66 (1), 1-5, 1981 | 169 | 1981 |
| Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer R Silvestrini, MG Daidone, G Di Fronzo, A Morabito, P Valagussa, ... Breast cancer research and treatment 7, 161-169, 1986 | 156 | 1986 |
| Relationship between proliferative activity and estrogen receptors in breast cancer R Silvestrini, MG Daidone, GD Fronzo Cancer 44 (2), 665-670, 1979 | 156 | 1979 |
| Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer. R Silvestrini, MG Daidone, A Luisi, P Boracchi, M Mezzetti, G Di Fronzo, ... Journal of clinical oncology 13 (3), 697-704, 1995 | 135 | 1995 |
| Current status of Milan adjuvant chemotherapy trials for node-positive and node-negative breast cancer G Bonadonna, P Valagussa, G Tancini, A Rossi, C Brambilla, M Zambetti, ... NCI Monogr 1, 45-49, 1986 | 134 | 1986 |
| Laminin receptors, collagenase IV and prognosis in node‐negative breast cancers MG Daidone, R Silvestrini, A D'Errico, GD Fronzo, E Benini, AM Mancini, ... International journal of cancer 48 (4), 529-532, 1991 | 126 | 1991 |
| Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine O Sanfilippo, E Ronchi, C De Marco, G Di Fronzo, R Silvestrini European Journal of Cancer and Clinical Oncology 27 (2), 155-158, 1991 | 123 | 1991 |
| Inhibiting effect of the new cytotoxic antibiotic daunomycin on nucleic acids and mitotic activity of HeLa cells A Di Marco, R Silvestrini, S Di Marco, T Dasdia The Journal of cell biology 27 (3), 545-550, 1965 | 122 | 1965 |
| Expression of p53, glutathione S-transferase-π, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer R Silvestrini, S Veneroni, E Benini, MG Daidone, A Luisi, M Leutner, ... Journal of the National Cancer Institute 89 (9), 639-645, 1997 | 121 | 1997 |
| Clinical studies of Bcl-2 and treatment benefit in breast cancer patients. MG Daidone, A Luisi, S Veneroni, E Benini, R Silvestrini Endocrine-related cancer 6 (1), 61-68, 1999 | 118 | 1999 |
| Cell kinetics as a prognostic indicator in node-negative breast cancer R Silvestrini, MG Daidone, P Valagussa, G Di Fronzo, G Mezzanotte, ... European Journal of Cancer and Clinical Oncology 25 (8), 1165-1171, 1989 | 118 | 1989 |
| Prognostic factors for metachronous contralateral breast cancer: a comparison of the linear Cox regression model and its artificial neural network extension L Mariani, D Coradini, E Biganzoli, P Boracchi, E Marubini, S Pilotti, ... Breast cancer research and treatment 44, 167-178, 1997 | 100 | 1997 |
